Order Article Reprints

Liu J, Grohganz H, Löbmann K, Rades T, Hempel N-J. Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies. Pharmaceutics. 2021; 13(3):389. https://doi.org/10.3390/pharmaceutics13030389

Liu, Jingwen, Holger Grohganz, Korbinian Löbmann, Thomas Rades, and Nele-Johanna Hempel. 2021. "Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies" Pharmaceutics 13, no. 3: 389. https://doi.org/10.3390/pharmaceutics13030389

Liu, J., Grohganz, H., Löbmann, K., Rades, T., & Hempel, N.-J. (2021). Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies. Pharmaceutics, 13(3), 389. https://doi.org/10.3390/pharmaceutics13030389